Financhill
Back

Aldeyra Therapeutics Vs. AbbVie Industry Stock Comparison

Sell
40

ALDX
Aldeyra Therapeutics

Last Price:
$4.87
Seasonality Move:
3.92%
Sell
40

ABBV
AbbVie

Last Price:
$175.68
Seasonality Move:
1.78%
Sell
40
Aldeyra Therapeutics (ALDX) is a Sell

Is Aldeyra Therapeutics a Buy, Sell or Hold?

  • The current Aldeyra Therapeutics [ALDX] share price is $4.86. The Score for ALDX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ALDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
AbbVie (ABBV) is a Sell

Is AbbVie a Buy, Sell or Hold?

  • The current AbbVie [ABBV] share price is $175.58. The Score for ABBV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALDX Stock Price Chart

What is Aldeyra Therapeutics's stock price today?

  • The Aldeyra Therapeutics share price today is $4.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALDX is experiencing slight selling pressure.

ABBV Stock Price Chart

What is AbbVie's stock price today?

  • The AbbVie share price today is $175.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 45.9 Sell
Chaikin Money Flow: -168401 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.69 - 5.17) Sell
Bollinger Bands (100): (4.58 - 5.8) Sell

ABBV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.42 Sell
Relative Strength Index (14 RSI): 46.96 Sell
Chaikin Money Flow: 10543412 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (169.89 - 179.79) Buy
Bollinger Bands (100): (178.35 - 198.21) Sell

ALDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.03 Sell
20-day SMA: 5 Sell
50-day SMA: 5.13 Sell
200-day SMA: 4.47 Buy
8-day EMA: 4.99 Sell
20-day EMA: 5.01 Sell
50-day EMA: 5.07 Sell
200-day EMA: 4.79 Buy

ABBV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 173.51 Buy
20-day SMA: 176.68 Sell
50-day SMA: 182.88 Sell
200-day SMA: 178.79 Sell
8-day EMA: 174.1 Buy
20-day EMA: 175.92 Sell
50-day EMA: 180.64 Sell
200-day EMA: 178.22 Sell

Aldeyra Therapeutics Earnings Growth & ALDX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $0.48 per share.

AbbVie Earnings Growth & ABBV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.24 per share.

Aldeyra Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

AbbVie Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):